Involvement of CD40-CD40L signaling in postischemic lung injury

被引:17
|
作者
Moore, TM [1 ]
Shirah, WB [1 ]
Khimenko, PL [1 ]
Paisley, P [1 ]
Lausch, RN [1 ]
Taylor, AE [1 ]
机构
[1] Univ S Alabama, Coll Med, Dept Physiol, Mobile, AL 36688 USA
关键词
inflammation; filtration coefficient; lymphocytes; macrophage inflammatory protein-2;
D O I
10.1152/ajplung.00016.2002
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Our studies show that ischemia-reperfusion (I/R) in the isolated rat lung causes retention of lymphocytes, which is associated with increased microvascular permeability, as determined by quantitative measurement of the microvascular filtration coefficient (K-f,K-c). Immunoneutralization of either CD40 or CD40L, cell surface proteins important in lymphocyte-endothelial cell proinflammatory events, results in significantly lower postischemic K-f,K-c values. Antagonism of CD40-CD40L signaling also results in attenuation of I/R-elicited macrophage inflammatory protein-2 production. Rat lymphocytes activated ex vivo with phorbol 12-myristate, 13-acetate increased K-f,K-c in isolated lungs independently of I/R, and this increase was prevented by pretreating lungs with anti-CD40. In addition to lymphocyte involvement via CD40-CD40L interactions, our studies also show that I/R injury is potentiated by antagonism of IL-10 produced locally within the postischemic lung, whereas exogenous, rat recombinant IL-10 provided protection against I/R-induced microvascular damage. Thus acute lymphocyte involvement in lung I/R injury involves CD40-CD40L signaling mechanisms, and these events may be influenced by local IL-10 generation.
引用
收藏
页码:L1255 / L1262
页数:8
相关论文
共 50 条
  • [1] Role of CD40-Cd40L signaling in experimental colitis.
    Vowinkel, T
    Anthoni, C
    Mori, M
    Senninger, N
    Krieglstein, C
    Granger, DN
    GASTROENTEROLOGY, 2005, 128 (04) : A509 - A509
  • [2] CD40-CD40L与肿瘤
    江恩利
    赵霞
    四川肿瘤防治, 2006, (01) : 57 - 61
  • [3] CD40-CD40L interactions in atherosclerosis
    Laman, JD
    deSmet, BJGL
    Schoneveld, A
    vanMeurs, M
    IMMUNOLOGY TODAY, 1997, 18 (06): : 272 - 277
  • [4] CD40-CD40L in Neurological Disease
    Ots, Heather D.
    Tracz, Jovanna A.
    Vinokuroff, Katherine E.
    Musto, Alberto E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [5] CD40-CD40L interactions in atherosclerosis
    Lutgens, E
    Daemen, MJAP
    TRENDS IN CARDIOVASCULAR MEDICINE, 2002, 12 (01) : 27 - 32
  • [6] CD40-CD40L与疾病
    易学瑞
    孔祥平
    国外医学(免疫学分册), 2001, (02) : 80 - 82
  • [7] CD40-CD40L interactions in platelet activation
    Davì, G
    Ferroni, P
    THROMBOSIS AND HAEMOSTASIS, 2005, 93 (06) : 1011 - 1012
  • [8] CD40-CD40L配体与肿瘤
    韩梅
    肖菊香
    王一理
    西部医学, 2005, (01) : 75 - 77
  • [9] The CD40-CD40L system in cardiovascular disease
    Pamukcu, Burak
    Lip, Gregory Y. H.
    Snezhitskiy, Viktor
    Shantsila, Eduard
    ANNALS OF MEDICINE, 2011, 43 (05) : 331 - 340
  • [10] Deficiency of CD40-CD40L signaling in DCs and T cells attenuates atherosclerosis
    Lacy, M.
    Gerdes, N.
    Buerger, C.
    Winkels, H.
    Reim, S.
    Weber, C.
    Atzler, D.
    Lutgens, E.
    EUROPEAN HEART JOURNAL, 2018, 39 : 886 - 886